Jim Baxter served from 2007 through 2018 as Senior Vice President of Development U.S. for Boehringer Ingelheim. He also oversaw from 2015 to 2017 all activities in BI Global Development that supported the development of the biological drug portfolio In these roles, Jim oversaw a wide range of non-clinical development activities in support of a portfolio of new drug candidates for the treatment of immunologic and oncologic disorders, diabetes and other medical conditions.
Prior to joining Boehringer Ingelheim, Jim worked from 1989 through 2007 at Pfizer in Groton, CT, where he served in site leadership roles in Global Pharmacokinetics, Dynamics and Metabolism, World-Wide Pharmaceutical Sciences.
Jim earned a B.S. in Pharmacy from the University of Rhode Island, and a Pharm D. and Ph.D. (Pharmaceutics) from the University of Buffalo. A long-time resident of Connecticut, Jim attended public schools in Shelton and Seymour, and resides in Waterford.